Elevated FGF21 concentrations are commonly observed in metabolic disorders, including diabetes, insulin resistance, and obesity, and have been associated with increased mortality in conditions like coronary disease, chronic kidney disease, cancer, and sepsis [4, 5, 6]. This evidence concerns the gene FGF21 and obesity disorder.